We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$21.2M
Cap. Flow
-$5.47M
Cap. Flow %
-1.02%
Top 10 Hldgs %
63.96%
Holding
32
New
5
Increased
3
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$41.1M
2
CTLT
CATALENT, INC.
CTLT
+$20.2M
3
TMDX icon
Transmedics
TMDX
+$17.8M
4
UTHR icon
United Therapeutics
UTHR
+$8.77M
5
ICLR icon
Icon
ICLR
+$6.43M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$35.4M
2
ISRG icon
Intuitive Surgical
ISRG
+$16.9M
3
NTRA icon
Natera
NTRA
+$9.65M
4
ILMN icon
Illumina
ILMN
+$8.78M
5
DXCM icon
DexCom
DXCM
+$8.37M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$39.8B
$49.3M 9.22%
219,495
-7,000
-3% -$1.41M
ICLR icon
2
Icon
ICLR
$12.8B
$46.6M 8.71%
186,200
+30,300
+19% +$6.43M
DHR icon
3
Danaher
DHR
$147B
$41.3M 7.72%
+194,112
New +$41.1M
UTHR icon
4
United Therapeutics
UTHR
$22.7B
$37.7M 7.05%
170,838
+39,600
+30% +$8.77M
ILMN icon
5
Illumina
ILMN
$29B
$31M 5.79%
169,928
-43,353
-20% -$8.78M
ISRG icon
6
Intuitive Surgical
ISRG
$139B
$29.8M 5.58%
87,290
-55,800
-39% -$16.9M
NTRA icon
7
Natera
NTRA
$45.9B
$29M 5.42%
595,694
-189,200
-24% -$9.65M
OM icon
8
Outset Medical
OM
$91.4M
$26.3M 4.91%
80,026
– –
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$29B
$26M 4.86%
136,756
– –
ARGX icon
10
argenx
ARGX
$54.2B
$25.1M 4.69%
64,400
– –
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$23.6M 4.42%
72,843
-28,700
-28% -$8.2M
LNTH icon
12
Lantheus
LNTH
$6.59B
$21.2M 3.97%
253,200
-31,600
-11% -$2.84M
DXCM icon
13
DexCom
DXCM
$33.1B
$20.9M 3.9%
162,400
-69,200
-30% -$8.37M
CTLT
14
DELISTED
CATALENT, INC.
CTLT
$19.9M 3.73%
+459,621
New +$20.2M
TMDX icon
15
Transmedics
TMDX
$3.07B
$19.5M 3.64%
+232,032
New +$17.8M
GH icon
16
Guardant Health
GH
$22.4B
$15.9M 2.98%
445,161
-151,400
-25% -$4.35M
PRCT icon
17
Procept Biorobotics
PRCT
$1.24B
$11.9M 2.23%
337,218
+53,000
+19% +$1.75M
SRPT icon
18
Sarepta Therapeutics
SRPT
$1.81B
$11.1M 2.08%
97,340
-41,300
-30% -$5.33M
ADPT icon
19
Adaptive Biotechnologies
ADPT
$4.05B
$8.15M 1.52%
1,214,860
– –
FDMT icon
20
4D Molecular Therapeutics
FDMT
$582M
$7.91M 1.48%
437,911
– –
TNDM icon
21
Tandem Diabetes Care
TNDM
$1.59B
$7.86M 1.47%
320,325
-105,200
-25% -$3.38M
AGIO icon
22
Agios Pharmaceuticals
AGIO
$1.95B
$7.58M 1.42%
267,630
– –
CANO
23
DELISTED
Cano Health, Inc.
CANO
$5.96M 1.12%
42,909
– –
FUSN
24
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$3.18M 0.59%
+680,370
New +$2.94M
AMWL icon
25
American Well
AMWL
$231M
$2.93M 0.55%
69,752
– –
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Eagle Health Investments's Q2 2023 Portfolio in Review

As of Q2 2023, Eagle Health Investments held 32 positions worth $535M, up 4.1% from $514M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Eagle Health Investments's Q2 2023 filing shows 5 new, 3 increased, 10 reduced and 5 closed positions. Its largest new stake was Danaher: 194,112 shares worth $41.3M. The largest sale was Seagen Inc. Common Stock, an estimated $35.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Eagle Health Investments's largest Q2 2023 buy was Danaher: 194,112 shares worth $41.3M.
  • Eagle Health Investments added most to United Therapeutics in Q2 2023, an estimated $8.77M increase.
  • Eagle Health Investments's biggest Q2 2023 reduction was Intuitive Surgical, cutting an estimated $16.9M.
  • Eagle Health Investments fully exited Seagen Inc. Common Stock in Q2 2023, selling an estimated $35.4M.
  • Eagle Health Investments's ten largest holdings make up 64% of its $535M portfolio in Q2 2023.
  • Eagle Health Investments opened 5 new positions and closed 5 in Q2 2023.
  • Eagle Health Investments's portfolio value rose 4.1% quarter-over-quarter to $535M.

Based on Eagle Health Investments's 13F filing for Q2 2023, filed 14 Aug 2023.